Related Experiment Video
Updated: Jan 22, 2026
Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice
Published on: December 27, 2024
Molecular foundations of primary spinal tumors-implications for surgical management
Tej D Azad1, Bowen Jiang2, Chetan Bettegowda2
1Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA.
Abstract:
Primary spinal tumors are rare lesions that require careful clinical management due to their intimate relationship with critical neurovascular structures and the significant associated risk of morbidity. While the advent of molecular and genomic profiling is beginning to impact the management of the cranial counterparts, translation for spinal tumors has lagged behind. Maximal safe surgical resection remains the mainstay of patients with primary spinal tumors, with extent of resection and histology the only consistently identified independent predictors of survival. Adjuvant therapy has had limited impact. To develop targeted neoadjuvant and adjuvant therapies, improve prognostication, and enhance patient selection in spinal oncology, a thorough understanding of the current molecular and genomic landscape of spinal tumors is required. In this review, we detail the epidemiology, current standard-of-care, and molecular features of the most commonly encountered intramedullary spinal cord tumors (IMSCT), intradural extramedullary (IDEM) tumors, and primary spinal column malignancies (PSCM). We further discuss current efforts and future opportunities for integrating molecular advances in spinal oncology with clinical management.
Insights
Primary spinal tumors require careful management due to their proximity to vital structures. Understanding their molecular landscape is crucial for developing targeted therapies and improving patient outcomes in spinal oncology.
Area of Science:
- Neuro-oncology
- Genomics
- Spinal Surgery
Background:
- Primary spinal tumors are rare and challenging due to neurovascular proximity and morbidity risks.
- Molecular profiling has advanced cranial tumor management, but lags for spinal tumors.
- Current treatments rely on maximal safe surgical resection, with limited adjuvant therapy impact.
Purpose of the Study:
- To review the epidemiology, standard-of-care, and molecular features of common spinal tumors.
- To highlight the need for molecular understanding to guide targeted therapies and improve prognostication.
- To discuss current and future integration of molecular advances into clinical spinal oncology.
Main Methods:
- Literature review of primary spinal tumors.
- Analysis of epidemiological data.
- Examination of molecular and genomic profiling in spinal oncology.
Main Results:
- Maximal safe surgical resection and histology are key survival predictors.
- Adjuvant therapies have shown limited efficacy.
- A gap exists in translating molecular advances to spinal tumor management.
Conclusions:
- A comprehensive understanding of the molecular and genomic landscape of spinal tumors is essential.
- Targeted neoadjuvant and adjuvant therapies require further research.
- Integrating molecular insights will enhance patient selection and treatment strategies in spinal oncology.
Related Concept Videos
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:25Urinary Tract Calculi VI: Surgical Management
01:24Physiological Foundation of Stress
Role of the Sympathetic Nervous System
Adrenaline triggers the...
01:20Social Foundations of Self II: The Generalized Other
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
01:30Theoretical Foundations of Nursing Practice
Theories provide a perspective to assess patients' conditions and organize data and methods. They also assist in analyzing and interpreting information. They represent a...